Table 1 Characteristics of the study cohort and association with mortality.

Age,y*

51 ± 16

1.67(1.46-1.90)

<0.001

Male

1316(57%)

0.91(0.65-1.28)

0.593

CO,L/min*

5.4 ± 1.5

0.84-0.75-0.95)

0.004

CI,L/min/m2*

2.8 ± 0.7

0.67(0.52-0.87)

0.002

LVEDV,ml*

170 ± 58

1.00(0.97-1.03)

0.836

LVEDV index, ml/m2*

0.87 ± 26

1.02(0.95-1.08)

0.627

LVESV,ml*

74 ± 48

1.04(1.01-1.07)

0.005

LVSV, ml*

97 ± 28

0.87(0.81-0.93)

<0.001

LVEF,%*

59 ± 12

0.76(0.67-0.86)

<0.001

Effective LVEF,%*

51 ± 12

0.71(0.63-0.79)

<0.001

RVEDV,ml*

161 ± 53

0.96(0.92-1.00)

0.027

RVEDV index,ml/m2*

82 ± 24

0.90(0.82-0.98)

0.018

RVESV,ml*

73 ± 36

0.99(0.94-1.04)

0.745

RVSV,ml*

89 ± 27

0.86(0.80-0.93)

<0.001

RVEF,%*

56 ± 9

0.84(0.70-1.00)

0.049

Cardiac ejection factor

NA

0.74(0.65-0.85)

<0.001

Cardiac outflow factor

NA

0.67(0.55-0.81)

<0.001